Market Capitalization (Millions $) |
8,338 |
Shares
Outstanding (Millions) |
56 |
Employees |
- |
Revenues (TTM) (Millions $) |
57 |
Net Income (TTM) (Millions $) |
-653 |
Cash Flow (TTM) (Millions $) |
500 |
Capital Exp. (TTM) (Millions $) |
16 |
Ascendis Pharma A
Ascendis Pharma A is a biopharmaceutical company that specializes in developing innovative therapies for rare endocrine diseases. The company is focused on utilizing its proprietary TransCon technology platform to create long-acting prodrug therapies. These therapies aim to improve patients' lives by providing sustained release and targeted treatment options, reducing the burden of frequent dosing and improving efficacy. Ascendis Pharma is known for its strong pipeline of product candidates, including treatments for conditions such as growth hormone deficiency, adult growth hormone deficiency, hypoparathyroidism, and others. The company is committed to advancing scientific research and delivering transformative therapies to patients in need.
Company Address: Tuborg Boulevard 12 Hellerup 0
Company Phone Number: 70 22 22 44 Stock Exchange / Ticker: NASDAQ ASND
|